Reviewed by Dr. Caio Trentin, MD ·
The Class
Tirzepatide is part of the GLP-1 class of medications used in metabolic and weight management. These medications act on the gut-hormone pathways that influence appetite, satiety, and how the body handles glucose. The clinical interest in this class has grown alongside a body of research on metabolic health. FORMA does not present tirzepatide as a brand-name product, and does not equate the compounded medication used here with any specific commercial drug. The compounded formulation is prepared individually under prescription. Whether this medication is appropriate for a given person is a clinical decision, determined at consultation.
Compounded, Not Off-the-Shelf
FORMA's tirzepatide is individually compounded and dispensed under physician prescription. Compounded means the medication is prepared for the individual patient rather than purchased as a finished commercial product. This distinction matters. It places the prescribing physician at the center of the protocol — responsible for dosing, titration, monitoring, and the decision to start, adjust, or stop. The medication is one component of a supervised plan, never a standalone purchase.
Physician Supervision Is the Protocol
Dr. Trentin's training in internal medicine shapes how FORMA handles this medication. A GLP-1 protocol is not a single appointment. It is an ongoing clinical relationship: baseline assessment, individualized dosing, scheduled follow-up, and adjustment based on response and tolerance. Internal-medicine oversight means the whole patient is considered — history, current medications, and the metabolic picture — not an isolated number on a scale. The consultation and the supervising decisions are Dr. Trentin's, performed in person.
Candidacy and Expectations
Tirzepatide is not for everyone, and FORMA does not treat it as a default offering. Candidacy depends on individual medical history, goals, and clinical evaluation. Outcomes vary between individuals and cannot be promised in advance; any expected response is discussed and individualized at consultation. The honest framing is that this medication works inside a supervised plan that may include lifestyle, nutrition, and ongoing monitoring — not in place of one.
What a Visit Looks Like
A first visit begins with a medical conversation, not a sale. Dr. Trentin reviews history, discusses goals, and evaluates whether a GLP-1 protocol is appropriate. If it is, dosing and a follow-up schedule are set individually. The plan is monitored and adjusted over time. FORMA serves patients across the South Florida region from its Fort Lauderdale practice.
Questions
Is FORMA's tirzepatide the same as a brand-name drug?
No. FORMA's tirzepatide is individually compounded under physician prescription. It is not presented as, and should not be assumed equivalent to, any specific commercial brand-name product. The medication is prescribed and supervised in person by Dr. Trentin.
Who supervises the treatment?
Dr. Caio Trentin, MD, supervises the protocol personally, with internal-medicine oversight. The consultation, dosing decisions, and follow-up are performed by the physician — not delegated to an injector.
How do I know if tirzepatide is right for me?
Candidacy is a clinical decision determined at consultation. Dr. Trentin reviews your medical history, current medications, and goals before recommending whether a GLP-1 protocol is appropriate. Outcomes are individualized and not guaranteed.